1 |
Discovery of a Novel Class of Agents that Inhibit EZH2 Activity and Lowers the Expression of Androgen Receptor and their Potential Utility in the Treatment of Castration-Resistant Prostate CancerHan, Zhengyang 15 June 2023 (has links)
No description available.
|
Page generated in 0.0551 seconds